Pioneering VisionTech

ARIA Research is pioneering the world’s first commercially scalable noninvasive bionic vision system, empowering over 338 million blind and vision-impaired people globally to perceive their surroundings through sound. By combining spatial computing, artificial intelligence, and user-centred co-design to create smart glasses, the system translates visual information into immersive 3D auditory cues.

Named 2023 Australian Tech and MedTech Company of the Year, ARIA has leveraged MedTech International’s strategic vision, industry expertise, and advocacy for inclusive innovation, which has been instrumental in its rapid growth and collaborations with leading blindness organisations and government partners. The partnership has been pivotal in driving ARIA’s product development, commercial strategy, and global planning, positioning the technology to deliver real-world impact for people with vision disability.

FoodTech Innovation

OmnisOva is an Australian biotechnology company focused on developing advanced breeding technology to produce safe eggs for people with severe egg allergies. With the support of a $1.47 million Cooperative Research Centres Project grant and in collaboration with industry and CSIRO, OmnisOva is working to remove ovomucoid (OVM), a key protein responsible for allergic reactions, from chicken eggs. This innovation aims to deliver allergen-safe eggs, addressing a significant unmet need for those who suffer from severe egg allergies.

As Executive Chairman, Warren leads the Board in setting OmnisOva’s strategic direction, strengthening partnerships with CSIRO and securing grant funding.

Warren’s experience in commercialisation and health innovation is helping position OmnisOva as a global leader in allergen-safe food solutions, to make safe eggs accessible to millions worldwide.

AgTech Revolution

Agscent is reinventing livestock diagnostics with non-invasive breath sensing technology that enables rapid, point-of-care pregnancy and disease detection, improving animal welfare, farm productivity, and sustainability.

As Non-Executive Chairman, Warren has played a key role in Agscent’s commercial strategy, product development, and industry partnerships.

His leadership has helped Agscent win industry recognition, commercialise its applications to methane gas measurement, and scale its impact across the agricultural sector, delivering cost savings, operational efficiency, and environmental benefits for farmers worldwide.

Disruptive HealthTech

Vlepis is revolutionising home and remote healthcare through advanced sensing solutions that enable proactive, personalised care.

By capturing and communicating contextual physiological data, Vlepis empowers caregivers and clinicians to make informed decisions and support the well-being of at-risk populations.

Engaging MedTech International for strategic advice and industry knowledge has supported Vlepis in refining its product offering, building partnerships, and aligning its technology with the evolving needs of the healthcare sector, positioning the company for growth in the rapidly expanding remote patient monitoring market.

AgeTech Mentorship & Advisory

Andromeda is transforming aged care by introducing personalised robot companions that bring residents joy, social connection, and improved wellbeing.

Connected through the LaunchVic MedTech Market Growth program, Warren’s mentorship and commercial advice have been vital in helping Andromeda’s founders navigate the complexities of scaling their health technology startup.

Leveraging Warren’s extensive network and expertise in MedTech innovation, MedTech International has provided strategic guidance on business development, funding, and market entry, accelerating Andromeda’s mission to combat loneliness and enhance the quality of life for older Australians.